Isoindoline compounds and methods of making and using the same

Details for Australian Patent Application No. 2005280499 (hide)

Owner Celgene Corporation

Inventors Man, Hon-Wah; Muller, George W.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005280499

PCT Pub. Number WO2006/025991

Priority 10/900,270 28.07.04 US

Filing date 27 July 2005

Wipo publication date 9 March 2006

Acceptance publication date 10 November 2011

International Classifications

C07D 209/46 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4035 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 209/48 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/025991 Priority application(s): WO2006/025991

10 November 2011 Application Accepted

  Published as AU-B-2005280499

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005280513-Photografic document imaging system

2005280496-Use of ALK 5 inhibitors to modulate or inhibit myostatin activity leading to increased lean tissue accretion in animals